ライフサイエンスコーパス: hepatology

1 to acquire additional training in Pediatric Hepatology.

2 actice in specific areas of gastroenterology/hepatology.

3 the most important diseases in the field of hepatology.

4 ools remains a research priority in clinical hepatology.

5 ion on the occasion of the golden jubilee of Hepatology.

6 over the past year in the field of pediatric hepatology.

7 nging obstacle for clinical and experimental hepatology.

8 ial applications to questions of interest in hepatology.

9 e an important adjunct to clinical trials in hepatology.

10 that could help standardize clinical care in hepatology.

11 dress these real disparities in the field of hepatology.

12 elian randomization as related to studies in hepatology.

13 ication of this diverse modality in clinical hepatology.

14 clinics are examples of established MDCs in hepatology.

15 health equity among professionals in GI and hepatology.

16 y in recent years, including in the field of hepatology.

17 practice providers whose practice was >=50% hepatology.

18 new era of clinical research and practice in hepatology.

19 icable to other implementation challenges in hepatology.

20 erapeutic inference toolbox toward precision hepatology.

21 of the therapeutic "black boxes" in clinical hepatology.

22 ade-offs, and purpose of pragmatic trials in hepatology.

23 ated by transplant hepatologists was general hepatology.

24 tions to both clinical and molecular data in hepatology.

25 er diseases as well as precision medicine in hepatology.

26 ential to influence the clinical practice of hepatology.

27 medicine, including the practice of clinical hepatology.

28 PCCs, 48 of 237 (20.3%) gastroenterology and hepatology, 190 of 236 (80.5%) were doctors of medicine

29 Hepatology, 62: 1828-1839.

30 Most hepatology (86%) and primary care (88%) recommendations

31 sociated with AUD treatment discussions with hepatology (adjusted odds ratio (aOR): 3.23, 95% confide

32 atric clinicians with experience in advanced hepatology allowed sub-sub-specialization to flourish.

33 astography has been a transformative tool in hepatology, allowing for the diagnosis and staging of li

34 were seen between the two groups (27.7% for hepatology and 33.6% for gastroenterology).

35 des a perspective on the status of trials in hepatology and a vantage point into the emerging capabil

36 emonstrating improved clinical outcomes when hepatology and addiction services are co-located.

37 f multidisciplinary integrated care model by hepatology and addiction teams for the management of dua

38 of in vivo experiments both in the field of hepatology and beyond.

39 n may have implications for both fundamental hepatology and cell-based therapies (e.g., bioartificial

40 uires a team approach with expertise in both hepatology and critical care.

41 will contribute to advancing the practice of hepatology and defining future research areas.

42 2016 at the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.

43 ultations and initial admissions seen by the Hepatology and Gastroenterology sections over a 3-month

44 ngle center case control study, conducted at hepatology and gastroenterology unit, Mansoura specializ

45 and experience from the perspectives of both hepatology and hematology beginning with a brief update

46 utic implications of the "new immunology" in hepatology and in other medical disciplines, have only b

47 Network, a group of international experts in hepatology and infectious diseases, discusses our curren

48 literature pertaining to machine learning in hepatology and liver transplant medicine.

49 alth services and policy research studies in hepatology and liver transplantation.

50 earch is a growing field of investigation in hepatology and liver transplantation.

51 d maintain multidisciplinary working between hepatology and metabolic clinicians.

52 rican Society of Pediatric Gastroenterology, Hepatology and Nutrition; the International Gastrointest

53 ussions were documented in less than half of hepatology and primary care encounters in patients with

54 rent issues facing training and workforce in hepatology and propose the next steps in conducting a wo

55 will change the face of clinical practice in hepatology and transplantation.

56 reports in this topic have been published in Hepatology , and it is fitting to review this research a

57 sure to be captured in the next 25 years by Hepatology , and to profoundly impact the prognosis of p

58 e medicine, 2 of 10 for gastroenterology and hepatology, and 3 of 10 for endocrinology and metabolism

59 is one of the most challenging conditions in hepatology, and due to our limited understanding of its

60 of experts in prison health, public health, hepatology, and infectious diseases and explore the clin

61 e (NAFLD) represents a burgeoning problem in hepatology, and is associated with insulin resistance.

62 opean Society of Pediatric Gastroenterology, Hepatology, and Nutrition allow for diagnosis of celiac

63 ican Society for Pediatric Gastroenterology, Hepatology, and Nutrition and opportunities provided by

64 pean Society for Pediatric Gastroenterology, Hepatology, and Nutrition diagnostic criteria (without h

65 pean Society of Paediatric Gastroenterology, Hepatology, and Nutrition nutrition committee.

66 diversity, health care disparities in GI and hepatology, and potential interventions to enhance workf

67 experts from anesthesiology/intensive care, hepatology, and transplant surgery were surveyed using t

68 reatment and with abstracts from nephrology, hepatology, and transplantation conferences.

69 s also a significantly increased interest in hepatology as a career (2.6 versus 3.0, P = 0.03).

70 p new recruitment strategies to the field of hepatology as well as ensure that non-gastroenterology-t

71 s B treatment by WHO, European, and American hepatology association criteria, respectively.

72 ed to the Department of Gastroenterology and Hepatology at Linkoping University Hospital in Sweden fr

73 copy to the Department of Gastroenterology & Hepatology at the University Hospital Basel in Switzerla

74 laints at the Division of Gastroenterology & Hepatology at the University Hospital Basel in Switzerla

75 In the September 12(th) , 2019 issue of Hepatology, Billey et al published a study assessing lab

76 MMSE has been used in hepatology but its usefulness in the evaluation of hepat

77 ificate of Added Qualification in Transplant Hepatology by the American Board of Pediatrics.

78 Participants received outpatient hepatology care at 3 SNHs between January 1, 2016, and D

79 es for cirrhosis and AUD who were engaged in hepatology care in a single healthcare system in 2015.

80 that access to specialty gastroenterology or hepatology care in cirrhosis is associated with higher a

81 g strategies to improve their integration in hepatology care.

82 ry atresia at the region's largest pediatric hepatology center before (January 2008-June 2011) or aft

83 e of admission to 12 North American tertiary hepatology centers from 602 patients in the North Americ

84 y weight per day) between 1999 and 2024 in 2 hepatology centers in Eastern Slovakia.

85 e Liver Disease consists of 16 tertiary-care hepatology centers that prospectively enroll nonelective

86 model in a second cohort of 14 tertiary care hepatology centers that prospectively enrolled nonelecti

87 formed at eight North American tertiary-care hepatology centers.

88 atresia diagnosed at the region's pediatric hepatology centers.

89 4 infection recruited from five academic and hepatology centres in Egypt.

90 Only 3.6% of the Hepatology charges were direct, compared with 15.9% of t

91 153/632 (24.2%) were offered hepatology clinic and 136/153 (88.9%) completed at least

92 accination rates in a tertiary care referral hepatology clinic and the impact of electronic health re

93 ctional study of patients with MASLD seen in hepatology clinic at University of Michigan.

94 20; P = .02), male sex (OR, 1.62; P = .003), hepatology clinic attendance (OR, 3.81; P < .001), and r

95 D patients followed at Emek Medical Center's Hepatology Clinic for SRDs and their autoantibodies.

96 present the case of a patient referred to a hepatology clinic for the evaluation of new-onset ascite

97 A 69-year-old Latino man was referred to Hepatology Clinic for urgent evaluation of new onset jau

98 ving with HIV at a single outpatient HIV and hepatology clinic in Chile for whom previous HBV vaccina

99 :2), placebo-controlled trial conducted at a hepatology clinic in the United States.

100 21 consecutive patients enrolled in the Duke Hepatology Clinic Research Database and Biorepository.

101 ctively recruited CHB patients attending the hepatology clinic to undergo shear wave elastography (SW

102 s non-invasive disease staging and minimizes hepatology clinic utilization to those with more advance

103 A temporary outreach hepatology clinic was set in Sihhu Township Health Cente

104 ge of incorporating new medications into the hepatology clinic, but this will be necessary with all m

105 identified in the Brooke Army Medical Center Hepatology clinic, were queried about their caffeine int

106 oximately 3 weeks prior to his evaluation in Hepatology Clinic.

107 nd treated at a tertiary referral hospital's hepatology clinic.

108 of patient medication information within the hepatology clinic.

109 Cs (45.6%) and 27 of 45 gastroenterology and hepatology clinicians (60.0%) reported that patients wit

110 e clinicians (PCCs) and gastroenterology and hepatology clinicians at 5 safety-net health systems in

111 e and compared PCCs and gastroenterology and hepatology clinicians.

112 P < .001) compared with gastroenterology and hepatology clinicians.

113 l intervention that can be incorporated into hepatology clinics and can be offered to most NASH patie

114 Obesity is highly prevalent in hepatology clinics and has a significant impact on chron

115 enrolled from subspecialty gastroenterology/hepatology clinics and lowest in studies characterizing

116 We enrolled HBV-infected patients from hepatology clinics at King Chulalongkorn Memorial Hospit

117 vational cross-sectional study in outpatient hepatology clinics at three teaching hospitals in Ghana,

118 ts with hepatitis B virus (HBV) infection at hepatology clinics in Thailand.

119 ded HCV genotype 1-infected outpatients from hepatology clinics with body weight >/=85 kg and HCV RNA

120 dence of liver disease were enrolled at four hepatology clinics.

121 Advances in molecular genetics challenge the hepatology community to understand and implement genetic

122 they present new treatment challenges to the hepatology community.

123 In addition, we searched abstracts for major hepatology conferences and contacted respective pharmace

124 experts in the fields of adult and pediatric hepatology, congenital cardiology (adult congenital and

125 Hepatology consultation assessed hepatic and autoimmune

126 ransient elastography (VCTE) examination (3) hepatology consultation for VCTE >= 8 kPa and (4) referr

127 and other factors including gastroenterology/hepatology consultation showed that patients seen by APP

128 Gastroenterology/hepatology consultation was also associated with improve

129 us disciplines including transplant surgery, hepatology, critical care, and bioethics, collaborated t

130 he Infectious Diseases, Immunodeficiency and Hepatology Department because of visual disturbances.

131 omatic 33-year-old woman was referred to the Hepatology Department in 2013 for work-up of indetermina

132 Thirty percent of patients had hepatology-documented AUD treatment recommendations and

133 e comprising 32 experts in gastroenterology, hepatology, endocrinology, and primary care providers fr

134 are needed to encourage clinicians to pursue hepatology, especially in areas outside of transplant ce

135 Few comparative effectiveness studies in hepatology exist to date, yet a growing number of analys

136 gators with extensive infectious diseases or hepatology expertise specific to HCV infection periodica

137 also were performed, and input from clinical hepatology experts was sought.

138 cle will provide a comprehensive overview of hepatology-focused AI research, discuss some of the barr

139 With tremendous growth in hepatology-focused AI, critical efforts are needed to co

140 maturation of the field led to definition of hepatology-focused curricular elements and educational c

141 This review delves into the AI literature in hepatology for diagnostic, prognostic, and therapeutic a

142 deficiencies exist in training programmes in hepatology for specialist registrars.

143 tis C virus (HCV) has dominated the field of hepatology for the past 25 years, and its cure in the ma

144 ed a panel of 15 HCV experts in the field of hepatology from India, Indonesia, Myanmar, Vietnam, Paki

145 In conclusion, although Hepatology generates only a small amount of direct charg

146 from the perspective of gastroenterology and hepatology (GH) specialists.

147 Hepatology had the highest rate of unkept appointments (

148 Pediatric hepatology has advanced greatly over the past few years.

149 ve but less procedurally oriented specialty, Hepatology has been considered a financial liability in

150 In the last decade, research into human hepatology has been revolutionized by the development of

151 In the past 10 or so years, paediatric hepatology has expanded into neighbouring clinical areas

152 The field of hepatology has experienced dramatic changes since the la

153 The field of hepatology has exploited this concept, and hepatocyte-li

154 Clinical research in hepatology has had a rich tradition in several domains,

155 The field of hepatology has made impressive progress over its ~75 yea

156 these successes, and the important role that Hepatology has played in disseminating them.

157 The fields of nonhospice PC and hepatology have ample opportunities to partner clinicall

158 on drug-induced cholestasis was published in Hepatology in 2011.

159 ver fibrosis are a huge need in contemporary hepatology in order to stratify patient's risk of advanc

160 Gastroenterology and hepatology in particular will be transformed due to the

161 nce and subsequent rapid growth of Pediatric Hepatology include: (1) an understanding of the dynamic

162 ologic processes within gastroenterology and hepatology, including gastrointestinal tract motility, m

163 ated human induced pluripotent stem cells in hepatology, including liver development, disease modelin

164 plinary team, including gastroenterology and hepatology, interventional radiology, hematology, and su

165 ), with expertise in epidemiology, genetics, hepatology, iron overload disorders, molecular biology,

166 The field of hepatology is no exception, with a growing number of stu

167 oteome studies in many areas of research and hepatology is no exception.

168 by CT was according to the Japan Society of Hepatology (JSH).

169 ous diseases, antimicrobial stewardship, and hepatology leaders to collaborate in development of an u

170 Much of the hepatology literature to date has focused on the adaptiv

171 In hepatology/liver transplantation, investigation of frail

172 As hepatology looks to the future, establishment of MDCs in

173 logistics of establishing and maintaining a hepatology MDC while also reviewing the emerging evidenc

174 These changes highlight opportunities for hepatology MDCs in alcohol-associated liver disease, met

175 er 2019, to the unit of Gastroenterology and Hepatology, Molinette Hospital, Turin, Northern Italy, s

176 l as other subspecialists (e.g., anesthesia, hepatology, nephrology, etc.) with training who are comf

177 t and to specialists in gastroenterology and hepatology, neurology, psychiatry, and paediatrics.

178 e attainable only through informal training, hepatology now has an accredited fellowship pathway and

179 ry surgeons [20%], 6 social workers [13%], 5 hepatology nurse practitioners [11%], and 2 critical car

180 e Lyon, Paediatric Hospital-Gastroenterology-Hepatology- Nutrition Department for further CD investig

181 hin the Paediatric Hospital-Gastroenterology-Hepatology- Nutrition Department, and the serological te

182 nts of Anesthesiology and Gastroenterology & Hepatology of the Academic Medical Center of Amsterdam a

183 2009 at the Departments of Gastroenterology/Hepatology of the Medical Universities of Vienna (traini

184 cotherapy, and transplantation, conventional hepatology often falls short in addressing the persisten

185 onger and concerted advocacy by professional hepatology organizations, and (4) advancing implementati

186 Fifty patients who attended a hospital hepatology outpatient clinic were interviewed using a qu

187 52 patients were recruited: 19 from the hepatology outpatient department and 33 from general med

188 alcohol consumption were recruited from the hepatology outpatient department or medical wards.

189 Patients were enrolled at 47 hepatology outpatient practices in the USA from Aug 19,

190 ic changes since the last workforce study in hepatology over 15 years ago.

191 vened a panel of specialists from radiology, hepatology, pathology, and basic science and physics to

192 The Hepatology patients generated 5,851,463 dollars in overa

193 In hepatology, pattern recognition in laboratory data and c

194 Hepatology practice has been dominated by hepatitis C bu

195 antation radically changed the philosophy of hepatology practice, enriched multiple areas of basic sc

196 nstrate the versatility of MRE in real-world hepatology practice, including its utility as a non-inva

197 s constitutes the most common entity seen in hepatology practice.

198 data exist on the relative contribution of a Hepatology practice.

199 es to integrate nonhospice PC within routine hepatology practice.

200 red to 81.8% of HBV monoinfected patients in hepatology practices (P < .00001).

201 As hepatology practices adapt to the "new normal," now is t

202 tematic screening for social barriers in our hepatology practices to identify gaps in the care cascad

203 trate methods to integrate PC within routine hepatology practices.

204 = 340 [27.9%]), and among practicing GI and hepatology professionals (n = 324 [26.6%]).

205 disparities among gastroenterology (GI) and hepatology professionals in the United States.

206 ions were calculated for adult and pediatric hepatology professionals.

207 Educating hepatology providers about PC principles and developing

208 There are several ways that hepatology providers can bridge the gap in health equity

209 A workforce study of hepatology providers in the United States was completed

210 t hepatology workforce and future demand for hepatology providers is not known.

211 In sensitivity analyses, a shortage of hepatology providers is predicted even under optimistic

212 Hepatology providers report lack of training to deliver

213 es for nonhospice PC integration would allow hepatology providers to improve clinical outcomes and QO

214 will be shortages of 10%, 23%, and 35% adult hepatology providers, respectively, and 19%, 20%, and 16

215 d pediatric workforce included 7,296 and 824 hepatology providers, respectively, composed of hepatolo

216 espectively, and 19%, 20%, and 16% pediatric hepatology providers, respectively.

217 ing critical shortage of adult and pediatric hepatology providers.

218 HSCT, paediatric intensive care, nephrology, hepatology, radiology, pathology, and transfusion medici

219 lly all with PAALD had been delivered before hepatology referral, mostly by cesarean section.

220 disease are a key component of translational hepatology research, yet there is no consensus on which

221 metabolome analyses to gastroenterology and hepatology research.

222 methods and mention several applications in hepatology research.

223 Integrative Hepatology-rooted in the principles of integrative medic

224 Our novel curriculum and nonelective hepatology rotation has effectively demonstrated improve

225 established a novel, nonelective, inpatient hepatology rotation that uses required modules in the Am

226 ., downstream effect) charges generated by a Hepatology section in comparison with a Gastroenterology

227 the importance of a hospital's support for a Hepatology section, especially in a center performing or

228 to include whole-person health, Integrative Hepatology seeks not to replace established therapies bu

229 adult hepatology services, 18 from pediatric hepatology services) was assembled, coded, and circulate

230 nymized study set of 50 cases (32 from adult hepatology services, 18 from pediatric hepatology servic

231 ing gradually more important in the field of hepatology since their incidence is slowly rising while

232 In the field of hepatology, social determinants of health (SDOH) are clo

233 force recommends that the 4 gastroenterology/hepatology societies work with the ABIM to develop a com

234 ional survey to members of 5 national GI and hepatology societies.

235 al survey to members of five national GI and hepatology societies.

236 cytopenia (OR, 2.06; 95% CI, 1.26-3.38), and hepatology subspecialty care (OR, 1.63; 95% CI, 1.09-2.4

237 ly, there are clinical practice areas within hepatology, such as liver transplantation, that already

238 For every 1 dollar billed by Hepatology, the hospital system generated an additional

239 In gastroenterology and hepatology, there were 58 physicians and APPs and 10 nur

240 r accuracy in answering questions related to hepatology, there were some deficiencies due to limitati

241 a sets in the fields of gastroenterology and hepatology to complement traditional means of diagnostic

242 hepatologists to evaluate the outputs of 10 hepatology topic questions generated by LiVersa, OpenAI'

243 ified Delphi panel with content expertise in hepatology, transplant surgery, psychiatry, transplant i

244 Patients were followed by hepatology/transplant until LT, and ultimately in posttr

245 pandemic and opportunities for innovation in hepatology trials are emphasized.

246 Over the first year after a baseline hepatology visit, 37 patients engaged in AUD treatment,

247 37 of 48 (77.1%) among gastroenterology and hepatology vs 65 of 142 (45.8%) among PCCs (P < .001).

248 dge of CLD, and increased career interest in hepatology was also observed after completion of the cur

249 members whose practice included 50% or more hepatology was conducted.

250 aterial for this article can be found on the HEPATOLOGY Web site

251 aterial for this article can be found on the HEPATOLOGY website.

252 aterial for this article can be found on the HEPATOLOGY website.

253 ons of Primary Care and Gastroenterology and Hepatology were enrolled in the pilot.

254 easing racial and ethnic diversity in GI and hepatology were insufficient representation of underrepr

255 this in mind, there are several areas within hepatology where these methods can be applied.

256 Future trials in hepatology will be driven by unmet therapeutic needs and

257 nt, but with collective effort, the field of hepatology will continue to make progress and overcome o

258 informed approach that combines conventional hepatology with complementary modalities to address the

259 The state of the current hepatology workforce and future demand for hepatology pr

260 in inpatient specialty care, and the current hepatology workforce cannot meet the demand of patients

261 is study was to model future projections for hepatology workforce demand.

262 duct an updated analysis of the state of the hepatology workforce.